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Amygdala-enriched genes identified by microarray
technology are restricted to specific
amygdaloid subnuclei
Mariela Zirlinger*, Gabriel Kreiman*, and David J. Anderson*†‡
*Division of Biology 216-76, †Howard Hughes Medical Institute, California Institute of Technology, Pasadena, CA 91125
Communicated by Giuseppe Attardi, California Institute of Technology, Pasadena, CA, February 26, 2001 (received for review December 7, 2000)
Microarray technology represents a potentially powerful method
for identifying cell type- and regionally restricted genes expressed
in the brain. Here we have combined a microarray analysis of
differential gene expression among five selected brain regions,
including the amygdala, cerebellum, hippocampus, olfactory bulb,
and periaqueductal gray, with in situ hybridization. On average,
0.3% of the 34,000 genes interrogated were highly enriched in
each of the five regions, relative to the others. In situ hybridization
performed on a subset of amygdala-enriched genes confirmed in
most cases the overall region-specificity predicted by the microar-
ray data and identified additional sites of brain expression not
examined on the microarrays. Strikingly, the majority of these
genes exhibited boundaries of expression within the amygdala
corresponding to cytoarchitectonically defined subnuclei. These
results define a unique set of molecular markers for amygdaloid
subnuclei and provide tools to genetically dissect their functional
roles in different emotional behaviors.
brain u cerebellum u hippocampus u olfactory bulb u gene chip
The mammalian brain is subdivided into cytoarchitectonicallyand physiologically distinct regions. Functional magnetic
resonance imaging (fMRI) and lesioning studies have suggested
that this anatomical parcellation reflects a modular functional
organization (1). A major goal of modern neurobiology is to
elucidate the functional roles of such brain modules, and of the
neuronal subtypes that comprise them, in mediating specific
behaviors. An important first step in applying the tools of
molecular biology to this goal is to identify molecular markers for
these subregions. Subtractive hybridization experiments have
suggested that such brain subregion-restricted genes do exist (2)
but have not been widely applied, perhaps because of their
technical difficulty.
Microarray technology represents a potentially powerful ap-
proach to identifying genes specifically expressed in different cell
or tissue types (3, 4). The application of microarray technology
to the brain, however, poses problems of interpretation not
encountered in more homogeneous cell populations, because of
its complex anatomical organization and extreme cellular het-
erogeneity. This anatomical complexity necessitates that mi-
croarray analysis be integrated with systematic in situ hybridiza-
tion studies to resolve the cellular distribution of identified
transcripts.
Here we report the application of such an integrated analysis
to the identification of genes expressed in the amygdala, a brain
region implicated in emotional behaviors (5, 6). In situ hybrid-
ization has revealed that the majority of genes identified as
amygdala-specific on microarrays exhibit intra-amygdaloid ex-
pression boundaries corresponding to cytoarchitectonically de-
fined subnuclei. These results support the idea that brain sub-
divisions detectable by classical neuroanatomical methods
reflect underlying differences in gene expression and demon-
strate that systematic identification of molecular markers for
such subregions is a feasible near-term goal.
Materials and Methods
Probe Preparation. Five brain regions were chosen for analysis
from 3-week-old male CD-1 mice: amygdala, cerebellum, hip-
pocampus, olfactory bulb, and periaqueductal gray (PAG). For
isolation of the amygdala and PAG, 34 mice were used. Thick
sections (500–600 mm) were sliced with a vibratome, and the
structures were dissected from these sections under a dissecting
scope, following delineations from the mouse brain atlas (7).
Dissected areas span approximately from 21.06 to 22.18 mm
and from 22.92 to 24.24 mm with respect to bregma, for
amygdala and PAG, respectively. Hippocampi, olfactory bulbs,
and cerebella were dissected in their entirety from 17 brains. At
least 5 mg of poly(A)1 RNA was purified from each brain region
and converted to ’20 mg of biotinylated cRNA hybridization
probe, according to the Affymetrix manual.
Affymetrix Microarray Technology. Oligonucleotide microarrays
(ref. 8; also known as GeneChips) comprising 34,325 murine
genes and expressed sequence tags (ESTs) were purchased from
Affymetrix (1 set 5 Mu11kA, Mu11kB, Mu19kA, Mu19kB, and
Mu19kC chips). Each gene or EST is represented on the
GeneChips by ’20 independent (nonoverlapping) ‘‘probe’’ se-
quences, each 25 nt in length. Each probe is located above a
control probe containing a single-base mismatch. A score
termed the ‘‘average difference’’ (D# ) is assigned to each gene,
calculated as the average signal from the 20 perfect-match
probes minus the average signal from the 20 corresponding
mismatch probes. Note that such average difference values can
therefore be .0 or ,0.
Hybridization and scanning of GeneChips were carried out at
a Howard Hughes Medical Institute facility at Stanford Univer-
sity (Stanford, CA). Because the purpose of the microarray
analysis was to identify candidate genes for in situ hybridization
analysis, rather than to provide accurate measurements of
individual transcript abundance, a single set of microarrays (see
above) was hybridized with each probe. However, independent
studies have reported considerable reproducibility in replicate
measurements using these arrays (9).
Data Analysis. Before analysis, the data were normalized to
correct for small differences in the amounts of each cRNA probe
applied to the microarrays. Normalization factors were calcu-
lated (Affymetrix GENECHIPS software) by comparing the mean
fluorescent intensity of each array with respect to the corre-
sponding amygdala array. On average, the mean D# value for each
amygdala array was 1,160. Normalized average difference values
were exported and analyzed with custom software (available at
Abbreviations: D# , average difference; PAG, periaqueductal gray; EST, expressed sequence
tag; SOM, self-organizing map.
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see Appendixes A and B, which are published as supplemental
data on the PNAS web site, www.pnas.org) written in MATLAB
(The MathWorks, Natick, MA). Two criteria were applied to
identify genes enriched in each of the five brain regions: (i) the
D# value for the gene in a given region; and (ii) the ratio (-fold
difference) of its D# value in that region relative to each of the
other four regions. For example, a given gene gi, with an average
difference value in the amygdala of D# gi
amyg, was considered to be
enriched relative to the other four regions if it satisfied the
following constraints for these two criteria:
D# gi
amyg . D# min [i]
@D# gi
amygyD# gi
other# . threshold; or @D# gi
amygyD# gi
other# , 0 [ii]
for all four other regions (cerebellum, hippocampus, olfactory
bulb, and PAG).
In Situ Hybridization. Male and female 3- to 4-week-old CD-1 mice
were used. Clones were purchased from Research Genetics
(Huntsville, AL) when available, or templates for probes were
synthesized by PCR using specific primers and cDNA from
mouse brain. For some genes, sense probes also were synthesized
to control for nonspecific hybridization. Digoxigenin-labeled
RNA probes were made and hybridization was performed
essentially as described (10), with some modifications (see
Appendix A). Adjacent sections were Nissl-stained for compar-
ison. Images were collected with a Zeiss Axioskop or an
Olympus IMT2 microscope attached to a charge-coupled device
camera and NEUROLUCIDA software (Microbrightfield, Colches-
ter, VT), using 35 mm film or electronically acquired composite
images, respectively.
Results
We used a custom algorithm to analyze the microarray data and
iterated the analysis with in situ hybridization experiments to
optimize search parameters (Fig. 1). Initial pairwise compari-
sons of the average difference values between each of the five
brain regions, for all genes on the Mu11kA array, failed to
identify obvious off-diagonal clusters indicative of differentially
expressed genes (see Fig. 5, which is published as supplemental
data on the PNAS web site). We therefore developed an
algorithm to simultaneously compare relative gene expression
levels among all five brain regions. We systematically varied
different parameters (see Materials and Methods) in this algo-
rithm to maximize the search for region-enriched genes. For
example, we searched for genes whose average difference values
were at least 3.5, 5, or 6 times higher in any given reference
region as compared with the remaining four. Based on in situ
hybridization experiments with genes identified in early itera-
tions of this search, we concluded that a threshold ratio of 3.5 was
optimal.
To filter out genes satisfying this ratio criterion, but whose
absolute expression levels were likely to be too low to be
detectable by our in situ hybridization procedure, we empirically
arrived at a minimum average difference value (D# min). For genes
enriched in the amygdala, for example, on the Mu11kA array
D# min was 110.4, corresponding to one-tenth of the mean D# value
for all genes on this array and approximately 5-fold above the
noise level of 22.5.
Analytical Characterization of Differentially Expressed Genes. We
found that only 455 of the 34,325 genes and ESTs analyzed
(1.3%) fulfilled our selection criteria for enrichment in any one
of the five brain regions, relative to the other four (Table 1). Of
these, 33 genes were enriched in the amygdala. On average, 0.3%
of the sampled genes were highly enriched in any one of the five
brain regions (Table 1). We also computed the number of genes
that were ‘‘present’’ (i.e., had significant expression above back-
ground levels) in all five regions, as well as those that had no
detectable expression. We found that 9,604 genes (28% of the
genes on the array) were expressed in all areas examined,
whereas 15,303 (45%) were present in none. Thus, of the 19,022
genes with detectable expression in one or more regions, half
were present in all regions. Among the present genes, only 2.4%
were differentially expressed in one region (455y19,022). A
complete table with all 455 genes or ESTs and their correspond-
ing D# values can be found in Table 3, which is published as
supplemental data on the PNAS web site.
To investigate whether certain classes of genes were prefer-
entially represented among these sequences, we classified all
annotated differentially expressed genes based on their structure
or function. Of the 455 sequences, 117 (26%) were annotated
genes. In four cases, annotation was accomplished by using 59
rapid amplification of cDNA ends (59 RACE) to clone the
coding region. The genes were classified among 21 different
functional categories, following the Gene Ontology (GO) Con-
sortium guidelines (11). The categories that were the most highly
represented (contained .7% of the 117 genes) comprised
signaling molecules (26%, n 5 30), DNA binding molecules
(17%, n 5 20), enzymes (15%, n 5 18), and structural proteins
(9%, n 5 10). Some examples of these are shown in Table 2. (See
Table 4, which is published as supplemental data on the PNAS
web site, for a full list of the functional categories and the
percentage of genes in each class for each of the five brain
regions analyzed.)
Several of these genes had previously been reported to be
Fig. 1. Schematic diagram of the strategy used to identify region-enriched
genes.
Table 1. Genes that are at least 3.5- or 5-fold enriched in each of
the five areas
Region
3.5-fold relative to
all four other areas
5-fold relative to all
four other areas
5-fold relative to any
three other areas
Amy 33 (0.1) 21 (0.1) 65 (0.2)
Cb 159 (0.5) 86 (0.3) 164 (0.5)
Hpc 89 (0.3) 57 (0.2) 105 (0.3)
OB 101 (0.3) 68 (0.2) 127 (0.4)
PAG 73 (0.2) 44 (0.1) 95 (0.3)
Total 455 (1.3) 276 (0.8) 556 (1.6)
Average 91 (0.3) 55 (0.16) 111 (0.3)
Number of enriched genes with respect to all four other regions or to any
three other regions are indicated. Percentage of total genes interrogated
(34,325) are in parentheses. Amy, amygdala; Cb, cerebellum; Hpc, hippocam-
pus; OB, olfactory bulb.
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enriched in their given areas. These included vasopressin (12, 13)
and arp-1 (14) in the amygdala, P400 (15) and Neuro-D (16, 17)
in the cerebellum, and tyrosine hydroxylase in the olfactory bulb
(18). Of 13 genes identified as cerebellum-enriched in a recent
GeneChip study (19), we independently identified 6. Of the
remaining 7 genes, 2 were rejected by our algorithm because they
had values ,0, and 5 were rejected because they also were
expressed at substantial levels in the olfactory bulb, a structure
not analyzed in the earlier study. However, as that study included
other brain regions such as the cortex, not examined in our
experiments, the two data sets are complementary.
To compare the performance of our search algorithm to that
of an independent method, we carried out a clustering analysis
using the GENECLUSTER program (20), which implements self-
organizing maps (SOMs). All genes identified by our method
also were included in SOM-derived clusters corresponding to
single region-enriched genes. However, the total number of
genes in each of these SOM clusters was about 6 to 10 times
larger than the number of genes identified by using our algo-
rithm, even with the use of stringent filters for SOMs. These
additional genes were rejected by our algorithm because they
either fell below D# min, or because their -fold difference relative
to the other four regions was too low. Nevertheless, several ‘‘best
candidates’’ among these genes were selected for in situ hybrid-
ization analysis (see below).
Validation of GeneChip Results by in Situ Hybridization. It was
essential to validate the results of the microarray analysis by an
independent method. We used in situ hybridization, rather than
biochemical assays such as RNase protection, because the com-
plex anatomical organization of the brain necessitates a method
with high spatial resolution. Thirty-five genes were analyzed by
in situ hybridization. Of these, approximately 60% were ex-
pressed in a manner consistent with the results of the microarray
analysis, 20% did not show any signal, 13% hybridized every-
where, and 7% were inconsistent with the microarray results
(i.e., hybridized more strongly to regions that were predicted to
have lower abundance). Because it was impractical to optimize
probe design and hybridization parameters for each gene, it is
possible that the actual false negative and false positive rate is
lower than we observed.
To determine the extent to which our algorithm conditions
could be further relaxed, we performed in situ hybridization
experiments for four best candidate genes identified by GENE-
CLUSTER that marginally failed to meet our selection criteria.
Three of these did not show any signal, but one was indeed
expressed in the amygdala (probe 41 in Fig. 2C). However, this
gene was identified by GENECLUSTER only with the use of a very
lax filter that included many other genes that fell well below our
selection criteria.
Strikingly, although our selection criteria required only a
3.5-fold difference in the level of expression in one region as
compared with the others, in many cases this seemingly modest
quantitative difference on the arrays translated into an apparent
qualitative difference when examined by in situ hybridization.
Thus, the expression of many amygdala-enriched genes simply
was not detected by in situ hybridization in the other regions
examined in the microarray analysis. This finding may reflect the
fact that many of the genes had fairly low average difference
values in the amygdala, so that a 3.5-fold lower level of expres-
sion in one of the other regions might be below the detection
limit of the nonisotopic in situ method. As might be expected,
most of the amygdala-enriched genes proved to be expressed in
at least one other brain area not tested in the microarray
experiment, such as the cortex (Fig. 3C).
The absolute D# values obtained from the microarrays do not
distinguish whether a given gene is expressed at high levels in a
small subpopulation of cells or at lower levels in a larger
population. Among the genes that we examined, one-fourth
(25%) showed strong expression in relatively small, scattered cell
populations, whereas the majority (75%) were expressed more
broadly. Because the pieces of tissue we dissected for RNA
isolation were relatively large and heterogeneous, it is likely that
our analysis was biased against genes expressed at lower levels in
small subpopulations of cells.
Amygdala-Enriched Genes Respect Subnuclear Boundaries. The
amygdala is a complex structure that can be anatomically
subdivided into at least 13 distinct regions (21), such as the
lateral, basolateral, medial, and central nuclei (Fig. 2A). This
structural organization raises two questions: (i) Do the bound-
aries of amygdaloid nuclei reflect boundaries of gene expression
domains?; and (ii) Do gene expression patterns reveal features
of amygdaloid organization not visible by classical neuroana-
tomical techniques? To address these questions, we examined in
detail the in situ hybridization pattern of 12 genes predicted by
the microarray analysis to be enriched in the amygdala.
Surprisingly, the majority (75%) of these genes exhibited
restricted, contiguous domains of expression, whose boundaries
at least partly coincided with those of amygdaloid subnuclei (Fig.
2A). (The remaining genes were expressed in scattered popu-
lations of cells.) Within this larger group of genes, approximately
50% completely respected nuclear boundaries (Figs. 2 B and C
and 3 A, C, and E). The other half respected nuclear boundaries
Table 2. Some examples of genes enriched at least 3.5-fold in each region
Region
Functional category
Signaling DNA-binding Structural
Enzyme- or
ligand-binding EST
Amy Vasopressin (M88354) arp-1 (X76653) Unconventional type myosin
(TC37197)*
ND TC35462 (activin
receptor type II)*
Cb Cerebellum P400 protein
(X15373)
Neuro-D (U28068) Pro-a-2 (I) collagen
(Msa.2220.0)
Parvalbumin (X67141) TC33451
Hpc ND Friend of GATA-1
(FOG) (AF006492)
Dynactin (Msa.12975.0) Neuropsin (D30785) TC36417
OB B219yOB receptor
(ET61693)
Dlx-1 (U51000) Pro-collagen type V a-2
(Msa.544.0)
Tyrosine hydroxylase
(M69200)
TC20543
PAG Angiotensinogen
precursor (Msa.7127.0)
Gata-2 (AB000096) ND Angiotensin-converting
enzyme (Msa.24687.0)
TC36249
Gene names and Affymetrix probe set names (listed in parentheses) are presented. ND, not detected among the 117 genes that were annotated. Abbreviations
are as in Table 1.
*Gene identity was determined with 59 rapid amplification of cDNA ends (59 RACE).
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along part of their length, but in places extended beyond these
boundaries into a well defined territory not coincident with any
described amygdaloid subdivisions (e.g., Fig. 3D, dotted vs.
dashed lines).
All of the amygdala-enriched genes we examined could be
parsed into three groups, according to the distinct ontogenetic
origins of the subnuclei in which they are expressed. One group
of genes (five genes; 42%) were expressed in the lateral, baso-
lateral, and cortical nuclei (Fig. 2 A, blue), which are cortical-like
structures embryologically derived from the pallium (22–24).
Probes 29 (activin receptor type II; Fig. 2B) and 75 (unconven-
tional type myosin; Fig. 3A) are characteristic of this group. The
second group (five genes; 42%) was formed by genes expressed
in the central and medial nuclei (Fig. 2 A, yellow), which have
subpallial (striatal or pallidal) origin. Probe 41 (laminin b3; Fig.
2C) is characteristic of this group. The third group (16%)
consisted of two genes, the transcription factor arp-1 (Fig. 2D)
and Ccte chaperonin « subunit (Fig. 3F), with widespread
expression throughout the amygdala, including pallial and sub-
pallial nuclei. Thus, the majority (84%) of the genes were
expressed in either of two subsets of amygdaloid subnuclei
related by a common developmental origin.
Fig. 2. In situ hybridization of amygdala-enriched genes. (A) Nissl staining of
a coronal section (left side of the brain). To the right, a schematic represen-
tation of various amygdala subnuclei is shown. Cortical-like nuclei (lateral,
basolateral, and cortical) are shown in blue. Striatal-like subdivisions (central
and medial) are in yellow, and the basomedial region is in orange (BMP 5
basomedial, posterior; BMA 5 basomedial, anterior). (B–D) Low magnification
pictures of the left hemibrain. Amygdala details are shown in the magnified
area (boxes). To the right are computer-aided schematics of staining in the
amygdaloid region. Note that the nuclear boundaries vary slightly depending
on the axial level. Color boundaries of subnuclei follow the diagram from A.
(B) Probe 29 (activin receptor type II, TIGR identifier TC35462). Intense labeling
in the lateral, basomedial, and cortical amygdala is apparent (black arrows).
Note that the medial nucleus is devoid of staining (white arrow). No signal was
detected in the cerebellum or PAG. Very few cells were stained in the olfactory
bulb (not shown). A sense probe (not shown) labeled the hippocampus and
piriform cortex (arrowheads) in the same way as the antisense probe, so the
signal in these regions may be mainly caused by nonspecific hybridization. (C)
Probe 41 (laminin b3, GenBank accession no. U43298). Signal is visible in the
medial amygdala (black arrow) and ventromedial hypothalamus (white ar-
row). No staining was detected in cerebellum, hippocampus, olfactory bulb,
and PAG (not shown). (D) Probe 4 (arp-1, GenBank accession no. X76653).
Strong signal is detected in the lateral and basolateral complexes (black
arrow). Note also weaker signal in the medial amygdala (white arrow). The
reticular thalamic nucleus also showed clear hybridization (arrowhead). No
staining was detected in the other four regions examined on microarrays (not
shown).
Fig. 3. Expression of amygdala-enriched genes in different amygdaloid
subnuclei. (A) Probe 75 (unconventional type myosin, TIGR identifier
TC37197). Note the sharp discontinuity in expression levels between the
lateral (arrow), and basolateral (arrowhead) nuclei. Staining was also ob-
served in cortical layers 2y3 (white arrow). No staining was detected in the
cerebellum, olfactory bulb, or PAG (not shown). (B) Probe 45–6 (Lhx6, Gen-
Bank accession no. AB031040). Lhx 6 hybridized to many scattered cells in the
forebrain and was particularly concentrated in the dorsal aspect of the medial
amygdala (arrow); the cerebellum was unlabeled (not shown). Lhx 6 was not
represented on the microarray, but was analyzed because of its coexpression
with Lhx7 (28, 29), which also was enriched in the amygdala (not shown). (C)
Probe 50 (neuronal pentraxin receptor, TIGR identifier TC18750). The expres-
sion domain matches the boundaries of the lateral and basolateral amygdala
(arrow). Staining also was observed throughout cortex (arrowhead) and in
hippocampus (not shown). No signal was detected in the cerebellum or PAG.
The olfactory bulb had weak staining (not shown). (D) Probe 28 (plasma
glutathione peroxidase, TIGR identifier TC31122). Intense labeling is apparent
in the medial amygdala (arrow), hypothalamus, and PAG (not shown). Note
also signal in a contiguous subregion of the basomedial amygdala (dotted
line). Two other genes also showed expression in this same region (not shown).
(E) Probe 68 [cerebrospinal fluid (CSF)-induced cysteine protease, TIGR iden-
tifier TC30215]. Hybridization in the basomedial amygdala (arrow) was de-
tectable. Staining also was observed in the hippocampus but was absent in the
remaining regions of study (not shown). (F) Probe 20 (Ccte chaperonin «
subunit, TIGR identifier TC30886). Signal was detected in the medial amygdala
(arrow) and in the lateral, basolateral, and basomedial complexes (not
shown). No staining was detected in the other four regions of study (not
shown). Probe numbers are in parentheses.
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Genes in the first and second groups also shared some other
features of their expression. For example, several of the genes in
the first group (e.g., probes 75 and 50, Fig. 3 A and C) also were
expressed to varying extents in the neocortex, consistent with the
pallial origin of the amygdaloid regions in which this group is
expressed. Conversely, a number of the genes in the second
group (e.g., probe 28 and probe 41, Figs. 3D and 2C) also labeled
the hypothalamus. Interestingly, all genes in the first group were
expressed in contiguous cell populations. This observation may
reflect the fact that the lateral and basolateral complexes are
relatively homogeneous with respect to both cell type and
neurotransmitter content (13, 25). By contrast, 80% of the genes
in the second (striatal) group, such as the neuropeptide vaso-
pressin, were expressed in scattered subpopulations of cells. This
observation is consistent with the fact that amygdaloid neu-
ropeptides are generally expressed in scattered cell populations
(26), and also that the centromedial aspect of the amygdala is the
most neuropeptide-rich region in the brain outside the hypo-
thalamus (27). Other genes in this subgroup included the Lim
homeodomain transcription factors Lhx-6 (Fig. 3B) and -7. It is
possible that these factors are involved in the regulation of
amygdaloid neuropeptide gene expression.
Discussion
The modular functional organization of the mammalian brain is
likely to reflect, at least in part, its anatomical parcellation into
distinct substructures. We have used microarray analysis in
conjunction with in situ hybridization to identify molecular
markers of this anatomical regionalization. By using commer-
cially available microarrays, we identified in each of five selected
brain regions, on average, 91 genes that were highly enriched.
This estimate is very close to that arrived at in a previous study
employing subtractive hybridization (2), which estimated the
number of transcripts highly enriched in the hypothalamus to be
on the order of 100. Our figure constitutes 0.3% of the ’34,000
genes interrogated, and 0.5% of all genes expressed in at least
one of the five areas (91y19,022). Similar values were recently
reported by Sandberg et al. (19), who analyzed the expression of
about 13,000 genes and ESTs in a different subset of brain
regions than we examined. These values may, however, be an
underestimate because genes expressed at low levels in small
subsets of cells may have been systematically excluded by both
analyses.
Among the differentially expressed genes with known func-
tion, 67% fell into 4 of 21 functional categories, comprising
signaling molecules, transcription factors, enzymes, or structural
proteins. However, the majority (72%) of the differentially
expressed genes were unannotated ESTs, making it difficult to
draw firm conclusions about categorical representation. It is also
likely that many other unknown region-specific genes exist,
which were not interrogated by the Affymetrix GeneChips.
Other microarray methods that do not rely on previous knowl-
edge of sequences may prove useful in identifying these.
Analytic Considerations. For simply identifying region-specific or
highly enriched genes, our custom algorithm proved more effi-
cient than SOMs cluster analysis (20). That is because our
program permits the explicit specification of multiple criteria for
‘‘enriched’’ genes. In contrast, GENECLUSTER identifies collec-
tions of genes that share similar features. Therefore, no con-
straint about the ratio of expression in one brain region relative
to all of the others can be independently set. However, SOM
analysis is designed for gene-profiling studies, where the com-
parison of expression patterns among a large collection of
samples is sought (20). This analysis is fundamentally different
from positively selecting highly enriched genes that fulfill specific
ratio criteria.
Validation of Microarray Data. A recent study (19) also used
Affymetrix GeneChips to characterize region-specific gene ex-
pression in the brain, but did not validate the microarray results
by in situ hybridization. Our results suggest that in situ hybrid-
ization is essential to confirm GeneChip data. Of the 35 genes
we tested, 80% yielded detectable in situ hybridization signals. Of
these, approximately 25% exhibited patterns apparently incon-
sistent with the microarray data. Thus, 60% of the 35 genes
examined were validated by in situ hybridization. Of the 14 cases
of inconsistency, most (65%) reflected probes that hybridized
everywhere. These cases may simply represent suboptimal probe
design rather than any inherent inaccuracy of the GeneChip
method. The remaining cases, however, constituted probes that
gave strong in situ signals in regions predicted to be weak or
negative by the microarrays. It is possible that replicate microar-
ray experiments with independently prepared samples and chips
would have lowered the number of false positives. However,
considering that at least 17 mice were used to prepare cRNA
probes from each brain region, it is unlikely that the discrepan-
cies we observed are attributable to inconsistent tissue dissection
or to biological differences between the animals used to prepare
microarray probes and those used for in situ hybridization.
Even for those genes whose in situ pattern was consistent with
the predictions of the microarray data, in situ hybridization was
also essential to identify sites of expression not included among
the original five samples. This is important, as it is technically
impossible to analyze every brain region or nucleus in a given
microarray experiment. Our in situ analysis also revealed how
extrapolating mRNA abundance levels based on D# values from
the microarrays is not necessarily informative, because this value
reflects both the abundance of a given transcript within express-
Fig. 4. Possible gene expression patterns in the amygdala and the percent-
age of amygdala-enriched genes examined that exhibited such patterns. (i)
Contiguous, panamygdaloid expression. (ii) Contiguous expression in subdo-
mains whose boundaries bear no relationship to those of classically defined
amygdaloid subnuclei. (iii) Expression in scattered cells contained within
specific subnuclei. (iv) Expression in scattered cells not respecting subnuclear
boundaries. (v) Contiguous expression in subdomains whose boundaries
match, at least in part, those of amygdaloid subnuclei. The majority of genes
examined (75%) exhibited pattern (v).
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ing cells as well as the proportion of cells expressing the
transcript in a given brain region. We have found examples of
genes with low D# values that were expressed at very high levels
in a few cells, and conversely, genes expressed broadly at more
modest levels that yielded high D# values.
Toward a Molecular Anatomy of the Amygdala. The amygdala, a
brain region implicated in emotional learning (5, 6), lies at the
interface between the cortex and subcortical structures such as
the striatum and hypothalamus, and therefore is well positioned
to integrate computational and neuromodulatory functions.
Accordingly, the amygdala is structurally heterogeneous, con-
sisting of over a dozen subnuclei (13, 21, 22). We made no special
effort to microdissect such subnuclei in preparing the microarray
hybridization probe; rather, a relatively crude dissection of the
entire amygdala was used. Thus, it is striking that 75% of the
amygdala-enriched genes that we examined by in situ hybridiza-
tion (n 5 12) exhibited expression boundaries at least partly
coinciding with those of one or more subnuclei (Fig. 4v). A priori,
this need not have been the case. At least four other kinds of
expression patterns could have been obtained (Fig. 4): (i)
uniform expression throughout the amygdala; (ii) contiguous
subdomains bearing no relationship to classically defined sub-
nuclei; (iii) scattered expression in cells contained within specific
subnuclei; and (iv) scattered expression not respecting sub-
nuclear boundaries. It is striking that no genes fell into either of
the first two categories. These data suggest not only that the
boundaries of amygdaloid subnuclei reflect gene expression
boundaries, but moreover that the majority of amygdala-
enriched genes may respect such boundaries. The genes we have
identified should, therefore, provide useful markers for amyg-
daloid subnuclei, some of which can be difficult to visualize by
Nissl staining on thin histological sections.
Our data also indicate, however, that not all gene expression
boundaries correspond precisely to boundaries of amygdaloid
subnuclei. For example, we observed three genes that had a
similar, well defined expression domain that included the medial
amygdala, but which extended into a limited subregion of the
adjacent basomedial amygdala (Fig. 3D, dotted line). Thus, gene
expression domains do not simply validate classically defined
anatomical units, but also may reveal organizational features not
easily visualized by existing staining techniques.
At present, the rate-limiting step in the analysis of microarray
data derived from the brain is its validation by in situ hybrid-
ization. When efficient, large-scale, high-throughput, automated
in situ hybridization procedures for adult brain sections become
available, it should be possible to exploit microarray data to
generate a ‘‘molecular brain atlas’’ in which each structure also
is delineated by its molecular repertoire. The results presented
here demonstrate that such a long-term goal is, in principle,
feasible. The genes identified by such an exercise, moreover, are
not simply markers, but also will provide tools to genetically
dissect the roles of such brain substructures in specific behaviors.
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